Search
Close this search box.
Search

Theranos restructures, sees COO Sunny Balwani leave

Theranos, an American blood testing startup, last week said Sunny Balwani, the company's president and chief operating officer, is stepping down and retiring.Balwani leaves of controversy concerning the reliability of the blood tests Theranos offers. Balwani has worked for Theranos since 2009. He was also a member of the board of directors of the company.
Theranos did not say goodbye, it also welcomed three new board members. Among them  biotech veteran Fabrizio Bonanni. he other two — William Foege and Richard Kovacevich — will move over from Theranos’ board of counselors. Bonanni was executive vice-president for biofarmaceutical  company Amgen (California), before retiring in 2013.

Theranos has been subjected to a controversy ever since the Wall Street Journal questioned the reliability of the blood testing Theranos offers. These tests are widely used as a cheaper an quicker alternative for traditional blood tests. Not longer after the articles in the WSJ a research by the US Centers for Medicare and Medicaid Services concluded Theranos’ Northern California lab was putting patients in ‘immediate jeopardy’. The lab hasn’t done any testing since.

Theranos has announced in a recent press release that it will restructure the organisation with dedicated corporate divisions for Technology and Clinical Operations. Balwani leaving Theranos has been the biggest change at the top since the Northern California lab was shut down in april, according to Business Insider. Since last april Theranos also announced a new medical advisory board.

Whixx

ICT&health World Conference 2024

Experience the future of healthcare at the ICT&health World Conference from May 14th to 16th, 2024!
Secure your ticket now and immerse yourself in groundbreaking technologies and innovative solutions.
Engage with fellow experts and explore the power of global collaborations.

Share this article!

Read also
Balancing regulatory compliance with seamless adoption, healthcare navigates the integration of AI solutions.
A guide to implementing AI in healthcare amid the EU AI Act
AmyWebb-Stephen-Olker
Futurist Amy Webb claims that wearables will evolve into "connectables"
Digital health solutions empower patients to better manage their health and integrate care into their daily lives.
How to improve Digital Patient Engagement to streamline workflows
For people with diabetes, inaccurate blood glucose measurements can lead to errors in diabetes management, including taking the wrong dose of insulin, sulfonylureas, or other medications that can rapidly lower blood glucose.
Smartwatches measuring glucose level: Harmful but easy to buy fake innovations
How to introduce innovation and AI in healthcare organizations if there is no business model for prevention and quality – Our interview with Professor Ran Balicer, the Chief Innovation Officer at Clalit Health Services and founding Director of Clalit Research Institute.
I see no legitimate rationale for delaying the digital transformation in healthcare
Pioneering Cardiac Arrest Detection for Enhanced Survival.
CardioWatch Revolutionizes Cardiac Arrest Detection
Dr. Oscar Díaz-Cambronero, Head of Perioperative Medicine Department at La Fe Hospital, spearheads innovative telemonitoring initiatives revolutionizing patient care
Smartwatches Saving Lives Inside and Outside the Hospital
EIT 2024
EIT Awards 2024. Two European startups are revolutionizing the treatment of cardiovascular diseases
Bertrand Piccard, Swiss explorer and founder of the Solar Impulse Foundation
EIT Summit 2024. What are the trigger points that drive or inhibit innovation?
MMC pioneers wireless monitoring for premature infants with the innovative Bambi Belt, revolutionizing care with improved comfort and mobility.
Wireless Monitoring of Vital Signs in Premature Infants at Máxima MC
Follow us